These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16269951)

  • 1. Do we need to target 'prediabetic' hypertensive patients?
    Segura J; Campo C; Ruilope LM; Rodicio JL
    J Hypertens; 2005 Dec; 23(12):2119-25. PubMed ID: 16269951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediabetes and cardiovascular risk in hypertensive patients.
    Segura J; Roldán C; García-Donaire JA; Ruilope LM
    Curr Hypertens Rep; 2006 May; 8(2):97-100. PubMed ID: 16672140
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of Prediabetes in the Metabolic Syndrome: Guilt by Association.
    Davidson MB
    Metab Syndr Relat Disord; 2023 May; 21(4):197-204. PubMed ID: 37042661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypertension associated with prediabetes].
    Barna I
    Orv Hetil; 2009 May; 150(20):917-23. PubMed ID: 19423489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic syndrome and prediabetic states].
    Galajda P; Mokáň M; Mokáň M
    Vnitr Lek; 2013 Jun; 59(6):453-8. PubMed ID: 23808738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should we treat hypertension and dyslipidemia in patients with prediabetes?
    Tsimihodimos V; Florentin M; Elisaf MS
    Curr Pharm Des; 2013; 19(21):3773-87. PubMed ID: 23286438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of conventional cardiovascular risk factors among hypertensive subjects with normal and impaired fasting glucose.
    Akintunde AA
    S Afr Med J; 2010 Sep; 100(9):594-7. PubMed ID: 20822649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysglycemia/prediabetes and cardiovascular risk factors.
    Hanna-Moussa A; Gardner MJ; Kurukulasuriya LR; Sowers JR
    Rev Cardiovasc Med; 2009; 10(4):202-8. PubMed ID: 20065930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glucose tolerance and impaired fasting glucose.
    Rao SS; Disraeli P; McGregor T
    Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequacies of absolute threshold levels for diagnosing prediabetes.
    Bergman M
    Diabetes Metab Res Rev; 2010 Jan; 26(1):3-6. PubMed ID: 20101658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: longitudinal study.
    Qiu M; Shen W; Song X; Ju L; Tong W; Wang H; Zheng S; Jin Y; Wu Y; Wang W; Tian J
    Hypertension; 2015 Mar; 65(3):525-30. PubMed ID: 25624343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediabetes: Why Should We Care?
    Zand A; Ibrahim K; Patham B
    Methodist Debakey Cardiovasc J; 2018; 14(4):289-297. PubMed ID: 30788015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediabetes: the importance of early identification and intervention.
    Hsueh WA; Orloski L; Wyne K
    Postgrad Med; 2010 Jul; 122(4):129-43. PubMed ID: 20675976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Poor control of risk factors prior to heart surgery. High proportion of undiscovered diabetes, undertreated hypertension and hyperlipidemia].
    Anderson RE; Brismar K; Lindberg A; Hylander S; Alserius T; Ivert T
    Lakartidningen; 2007 Mar 21-27; 104(12):936-40. PubMed ID: 17469307
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
    Lindholm LH; Ibsen H; Borch-Johnsen K; Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Beevers G; de Faire U; Fyhrquist F; Julius S; Kjeldsen SE; Kristianson K; Lederballe-Pedersen O; Nieminen MS; Omvik P; Oparil S; Wedel H; Aurup P; Edelman JM; Snapinn S;
    J Hypertens; 2002 Sep; 20(9):1879-86. PubMed ID: 12195132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study.
    Burchfiel CM; Hamman RF; Marshall JA; Baxter J; Kahn LB; Amirani JJ
    Am J Epidemiol; 1990 Jan; 131(1):57-70. PubMed ID: 2293753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediabetes and hypertension.
    Sahib AK; Sahu SK; Reddy KN
    J Indian Med Assoc; 2007 Jan; 105(1):25-8. PubMed ID: 17802973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediabetes and cardiovascular complications screening in Nigeria: A family case presentation.
    Anyasodor AE; Nwose EU; Richards RS; Bwititi PT; Mudiaga LI; Aganbi E
    Diabetes Metab Syndr; 2017; 11(4):273-275. PubMed ID: 28043816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
    ; ; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes HP; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen MR; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
    Diab Vasc Dis Res; 2014 May; 11(3):133-73. PubMed ID: 24800783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.